A morphologic study of chronic type B aortic dissections and aneurysms after thoracic endovascular stent grafting  by Qing, Kai-xiong et al.
From the Western Vascular Society
A morphologic study of chronic type B aortic
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Stephen W. K. Cheng, MBBS, FRCS (Eng), FRCS (Edin), Hong Kong
Background: The long-term results of treating chronic aortic dissections and aneurysms in association with dissections
with thoracic endovascular aortic repair (TEVAR) are unknown, and the timing for intervention is uncertain. We
evaluated themorphology of stent graft and aorta remodeling and the volumetric changes in these patients after successful
TEVAR.
Methods: Serial computed tomography scans of 32 patients who underwent TEVAR for uncomplicated chronic dissections
(group A, n  17) and chronic dissections with aneurysms (group B, n  15) were analyzed at 1, 6, 12, and 36 months.
Stent graft diameter changes and positional migration were assessed three-dimensionally usingMimics 14.0 (Materialize,
Leuven, Belgium). Volumetric data for true lumen, false lumen, thrombus load, and aortic size were measured by
Aquarius iNtuition 4.4 software (TeraRecon, SanMateo, Calif). Results were compared between the two groups andwith
stent graft diameter, length, and oversizing.
Results: Aortic stent grafts remodeled progressively, with inlet area increasing 4.4%, 10.1%, and 14.2% and outlet area
increasing 42.6%, 67.2%, and 72.3%, respectively, at 6, 12, and 36 months. True lumen volume increased progressively
in group A (114 to 174 mL) and group B (124 to 190 mL) from baseline to 36 months. False lumen volume decreased
in group A (150 to 88 mL) and group B (351 to 250 mL), whereas thrombus load in the false lumen increased from 73%
to 80% in group A and 84% to 87% in group B in 3 years. Eight patients (4 in each group) showed an increase in total aortic
volume of >10%, 12 showed a static volume, and 12 showed shrinkage. Aortic volume change had no relationship to
pathology, stent graft sizing, and thrombus load but was positively associated with the placement of a longer graft. A
small but progressive distal migration of stent grafts was noted in all patients (3.1, 4.5, and 5.1 mm at 6, 12, and 36
months) but was more prominent in shorter stent grafts (<162 mm). No deaths, rupture, or secondary interventions
occurred during follow-up.
Conclusions: Aortic remodeling after TEVAR in chronic dissection is a continuous process. There were no significant
differences between chronic dissections and aneurysms in all volumetric parameters. Treating chronic dissections early,
before aneurysm formation, did not appear to have a morphologic advantage. (J Vasc Surg 2012;55:1268-76.)
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fEndovascular stent grafts can be used to treat patients
with type B aortic dissections.1,2 Many multicenter trials
have reported superior outcomes of thoracic endovascular
aneurysm repair (TEVAR) in treating acute type B aortic
dissection compared with medical treatment or open sur-
gical interventions. Data from the International Registry of
Acute Aortic Dissections (IRAD) also suggested that endo-
vascular treatment offers better short-term outcomes for
survival and associated complications for acute type B dis-
section than open repair.3,4
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1268In the chronic stage, about one-third of the dissected
horacic aorta will gradually dilate in time, due to the
eakened aortic wall, with eventual aneurysm formation.
he long-term survival of patients with chronic type B
issections is adversely affected by aneurysm rupture and
eath associated with secondary surgical interventions. A
ontinuing patent false lumen is a risk factor for long-term
eath.5
The role of TEVAR in treating chronic asymptomatic
ortic dissections and resulting aneurysmal degeneration
emains unclear. Several single-institution studies have
laimed that TEVAR is a safe and effective procedure to
reat chronic dissections. Xu et al6 reported a 5-year actu-
rial survival rate of 84% for chronic dissections managed
ith stent grafts. Parsa et al7 reported a 30-day mortality
ate of 5% for chronic dissection patients treated with
EVAR and found a decreased pressure in false lumen after
raft deployment. In contrast, results from the Investiga-
ion of Stent Grafts in Aortic Dissection (INSTEAD) trial
howed that TEVAR failed to improve 1-year and 2-year
urvival and adverse event rates in treating chronic dissec-
ions compared with medical treatment, despite achieving
avorable false lumen thrombosis and a reduction in false
umen diameter.8,9
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Volume 55, Number 5 Qing et al 1269The goal for treating chronic type B aortic dissection
with endovascular stent grafting is to seal the primary tear,
improve true lumen perfusion, and therefore, reduce false
lumen pressure and expansion. The best timing for endo-
vascular intervention is controversial. Proponents of early
TEVAR suggest that the chance of achieving better mor-
phologic outcome is higher when the false lumen is small
and the flap is still mobile and that the risks of incomplete
false lumen thrombosis and stent graft migration are lower
due to a smaller false lumen volume and a better distal
landing zone. Although the clinical end points of aortic
rupture, death, and persistent aneurysmal expansion and
reintervention cannot be determined without long-term
follow-up, the morphologic benefits of TEVAR in true and
false lumen volumetry, thrombus formation, and stent graft
remodeling and migration can be studied with serial com-
puted tomography (CT) scans.
We evaluated these morphologic changes in the dis-
sected aorta after successful TEVAR to determine whether
there is any morphologic advantage in treating patients
with uncomplicated chronic type B aortic dissections and
aneurysms.
METHODS
We studied serial CT images of 32 patients with chronic
uncomplicated type B aortic dissection who underwent
successful TEVAR and were followed up to 36 months.
Patients were selected if the onset of dissection to TEVAR
had exceeded 4 weeks with CT follow-up over 1 year.
Intraluminal hematomas and penetrating ulcers were ex-
cluded. Patients were categorized as having chronic type B
aortic dissections (group A) if their maximum aortic diam-
eters were 50 mm (n  17) and as having chronic
dissections with aneurysms (group B) if their maximum
aortic diameters were 50 mm (n  15). CT scans were
performed at 1, 6, and 12 months, and yearly thereafter,
Fig 1. Area measurement on multiplanar reconstructed
definition and measurement (green circle); Right, outletusing a standard protocol of 2.5-mm cuts. The Digital pmaging andCommunications inMedicine (DICOM) data
ere available for analysis. True and false lumen volumetry,
hrombus formation, and stent graft remodeling and mi-
ration were determined by computer-assisted measure-
ents.
True and false lumen volumetry. A three-dimensional
3D) reconstruction software, Aquarius iNtuition 4.4
TeraRecon, San Mateo, Calif), was used to measure the
orta volumetrically. On 3D images reconstructed fromCT
ICOMdata, the free region of interest tool was applied to
efine the true lumen and false lumen separately. With
lice-by-slice definition, the software generated the volume
nformation of the selected vessel semiautomatically.
hrombus volume in the false lumen was calculated after
xcluding visible flows by the dynamic region growing tool.
rue lumen volume was measured proximally from the
nlet of the implanted stent graft to the lowest renal artery
evel. False lumen volume and thrombus volume were
easured from the top of the aortic arch to the lowest renal
rtery level. Aortic volume was determined by the sum of
he true and false lumen volume. Volume changes over
ollow-up were considered significant if 10% growth or
hrinkage occurred compared with the baseline volume.
Stent graft remodeling. The inlet and outlet areas of
he stent grafts were measured on multiplanar reconstruc-
ion (MPR) images. The orientation of theMPR image was
anipulated to obtain a plane parallel to the inlet of the tips
f the stents, and the inlet area was measured by using a
ollick 0604 graphics tablet (Hanvon, Beijing, China; Fig
). The outlet area was measured using the same method.
Stent graft migration. A 3D surface-meshing soft-
are, Mimics 14.0 (Materialize, Leuven, Belgium), was
sed to precisely evaluate the migration of stent graft using
TDICOMdata. The center of the common carotid artery
CCA) origin was designated as the reference point, offset
o (0, 0, 0) in a 3D coordinate system. The uppermost
ges on TeraRecon iNtuition software: Left, Inlet area
definition and measurement (green circle).imaoint on the inlet ring of the stent graft was defined by 2D
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May 20121270 Qing et alCT images on the three mutually perpendicular planes,
using the computer-aided design (CAD) tool in the Med-
CAD module (Fig 2). The coordinate of this point was
recorded as (x, y, z). In the follow-up CT scan of the same
patient, the center of CCA origin was also designated as
origin with the coordinate of (0, 0, 0), and the stent graft
uppermost point was recorded as (a, b, c). Distance from
point (x, y, z) to point (a, b, c) was defined as the migration
Fig 2. Migration measurement on Mimics: A1-A3, Lo
stent graft on coronal, axial, and sagittal views (red point
left common carotid artery on coronal, axial, and sagittal
reconstructed image shows locations of uppermost poin
artery (green point with green arrow).of the stent grafts by: lMigration(x a)2 (y b)2 (z c)2
The morphologic data were analyzed at baseline, 6
onths, 1 year, and 3 years and were compared between
he two groups of chronic dissection and aneurysms. They
ere also compared with additional stent graft parameters
ecorded, including the diameter, length, and percentage
f oversizing at the proximal landing zone. Stent graft
n is shown of the uppermost point on the inlet ring of
red arrow). B1-B3, Location is shown of the center of
(green point with green arrow). C, A three-dimensional
point with red arrow) and center of common carotidcatio
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Volume 55, Number 5 Qing et al 1271centerline technique on TeraRecon. Stent graft coverage of
162 mm was defined as long and lengths 162 mm as
short. Continuous variables were compared with the t-test
and repeated measures analysis of variance. Categoric vari-
ables were tested with 2 and Fisher exact tests.
RESULTS
Of the 32 patients included, 17 were categorized as
having uncomplicated chronic type B aortic dissections
(group A) and 15 as chronic dissections with aneurysms
(group B). All patients were treated with Zenith TX2
thoracic endografts (Cook Medical Inc, Bloomington,
Ind). The graft oversizing criterion was selected to be 10%
to 20% (mean, 15.9% 7.9% oversizing). Eighteen patients
were treated with short graft coverage. Mean patient ages
were 58.4 8.9 years in group A and 54.1 14.2 years in
group B (P  .303). The mean follow-up time of all
patients was 31.7 17.0months (range, 10-63.2months):
39.8  16.6 months for group A and 22.6 12.5 months
for group B.
Progressive stent graft remodeling was evident in all
patients. The stent graft inlet area increased by 4.4%,
10.1%, and 14.2% and outlet area increased by 42.6%,
67.2%, and 72.3%, respectively at 6, 12, and 36 months
(P  .001; Fig 3; Table I). The inlet/outlet area ratio
decreased gradually during the 3-year follow-up. There was
no statistical significant difference in the stent inlet and
outlet expansion between group A and group B.
True lumen volume increased progressively in group A
(114 to 174 mL) and group B (124 to 190 mL) from
baseline to 36 months, respectively, and false lumen vol-
ume also decreased in group A (150 to 88 mL) and group
B (351 to 250 mL). The mean total aortic volume
showed little change through the 36-month follow-up
(363 to 346 mL; P .218). Thrombus percentage in the
false lumen increased from 72.5% to 80.3% in group A
and 83.6% to 86.8% in group B during the 3-year follow-
up. Patients treated with long grafts showed a higher
percentage of thrombus in their false lumen at 6 (P 
.01) and 36 months (P  .014; Table II). Differences in
volumetric remodeling between the two groups were not
Fig 3. Progressive stent graft remodeling. A, Inlet and
grafts. TBAD, Type B aortic dissection.significant (Fig 4; Table I). aThe total aortic volume decreased in 12 patients and
emained static in another 12. Progressive expansion of the
ortic volume was noted in eight patients (25%, 4 in each of
roup A and B). Three of these eight patients were im-
lanted with short stent grafts (162 mm). Aortic volume
hanges had a marginally significant positive association
ith the length of stent graft coverage (P .056; Table II),
ut had no relationship to pathology (P .838), stent graft
versizing (P  .815), inlet/outlet area ratio of the de-
loyed stents (P  .412), or thrombus load (P  .551).
There was a small but progressive distal migration of
tent grafts in all patients of 3.1, 4.5, and 5.1 mm, respec-
ively, at 6, 12, and 36 months (Fig 3; Table I). The
igration process was more prominent within the first 12
onths and slightly more common with short stent grafts
P  .071; Fig 3; Table II).
One patient in group A was complicated with retrograde
ype A dissection 1 month after discharge, presenting with
cute chest pain, and was successfully treated surgically by
mergency ascending aorta replacement. One patient with
ortic volume increase in group B required secondary inter-
ention due to distal thoracoabdominal aneurysmal expan-
ion, and an additional distal fenestrated extension was placed
4 months later. The remaining seven patients with volume
ncrease from both groups were managed conservatively with
lose follow-up because no amenable course had been identi-
ed. No deaths, rupture, or further secondary interventions
ccurred during follow-up (Table III).
ISCUSSION
Deaths caused by type B aortic dissections occurred
ostly in the acute phase. In the chronic stage of the
isease, the patients are usually asymptomatic. Estimates
re that about one-third of dissected aorta will progress to
neurysm. Aneurysms in association with chronic dissec-
ions are often anatomically complex, difficult to treat
urgically, and require cardiopulmonary bypass, resulting in
igh mortality and paraplegia rates. The rationale of treat-
ng these patients would be to prevent or slow the rate of
neurysm formation. TEVAR has evolved as a minimally
nvasive alternative to treat chronic dissections but did not
et area change. B, Progressive distal migration of stentoutlppear to convey any cumulative survival advantage in the
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May 20121272 Qing et alTable I. Aortic remodeling parameters compared between group A and group Ba
Variableb All patients Group A Group B P
Inlet area change, % .267
6 months 4.4  1.6 4.9  9.9 3.9  7.7 .760
12 months 10.1  2.4 15.8  13.9 12.6  18.1 .584
36 months 14.2  2.9 8.6  8.6 11.8  17.5 .511
Outlet area change, % .206
6 months 42.6  7.4 36.1  39.5 49.1  41.9 .388
12 months 67.2  11.0 55.1  51.7 81.1  67.7 .245
36 months 72.3  10.4 66.2  49.1 78.9  67.7 .554
Inlet/outlet ratio .294
Baseline 1.90  0.85 1.97  0.95 1.82  0.76 .631
6 months 1.58  1.09 1.89  1.43 1.25  0.36 .104
12 months 1.45  1.05 1.73  1.36 1.11  0.27 .109
36 months 1.46  1.12 1.75  1.48 1.13  0.24 .116
True lumen volume, mL .188
Baseline 118.9  45.2 114.0  44.6 124.4  46.8 .948
6 months 161.5  59.5 146.9  48.5 178.1  67.9 .607
36 months 181.9  61.2 174.4  45.1 190.3  76.3 .172
False lumen volume, mL .224
Baseline 244.2  177.8 150.2  65.7 351.2  205.2 .001
6 months 172.8  127.5 106.7  77.1 247.8  133.8 .024
36 months 163.6  148.6 87.8  81.4 249.6  162.6 .023
Thrombus volume, mL .231
Baseline 199.3  169.2 111.0  55.1 299.5  199.1 .001
6 months 145.5  118.3 82.1  60.1 217.4  128.2 .014
36 months 138.7  136.0 80.0  68.2 215.5  154.1 .032
Thrombus percentage, % .513
Baseline 77.7  15.4 72.5  15.2 83.6  13.9 .670
6 months 81.4  14.9 76.6  11.7 86.9  16.6 .723
36 months 83.4  15.7 80.3  14.4 86.8  16.9 .922
Aortic volume, mL .392
Baseline 363.3  176.8 264.2  78.5 475.6  191.6 .001
6 months 334.3  150.8 253.5  84.1 425.9  159.3 .001
36 months 345.5  175.2 262.2  102.0 440.0  195.1 .003
Migration, mm .081
6 months 3.1  5.5 3.7  6.3 2.4  4.7 .511
12 months 4.5  6.0 5.0  6.6 3.9  5.3 .606
36 months 5.1  5.9 6.6  6.5 3.3  4.8 .121
aMeans between the two groups were tested with one-way analysis of variance; progressive remodeling processes were tested with analysis of variance (repeated
measures).
bData are shown as mean  standard deviation.Table II. Comparison of aortic volume, thrombus percentage, andmigration between patients who received long and short graftsa
Variableb All patients Short graft Long graft P
Thrombus percentage, % .064
Baseline 77.7  15.4 76.0  16.2 79.8  14.7 .500
6 months 81.4  14.9 75.6  15.8 89.0  10.0 .010
36 months 83.4  15.7 77.5  17.4 91.0  9.0 .014
Aortic volume change .056c
Increase 8 3 5
Static 12 10 2
Decrease 12 5 7
Migration, mm .071
6 months 3.1  5.5 4.5  6.5 1.4  3.5 .132
12 months 4.5  6.0 5.2  7.1 3.5  4.1 .431
36 months 5.1  5.9 5.5  7.0 4.5  4.2 .619
aMeans between the two groups were tested with one-way analysis of variance; progressive remodeling processes were tested with analysis of variance repeated
measures.
bContinuous data are shown as mean  standard deviation; categoric data as count.
cFactors tested with 2 test.
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tions.8,9
Treating chronic aortic dissection with TEVAR has
several unique anatomic concerns. The proximal stent graft
Fig 4. Volumetric remodel process of uncomplicated ch
with aneurysm. A, Volume change of true lumen and fals
lumen. C, Thrombus percentage increase during follow-
Table III. Clinical procedures and outcomes of thoracic e
dissections (TBAD) and aneurysms
Variablea
Uncomplicated
TBAD
(n  17)
Subclavian occlusion 13
Carotid-subclavian bypass 2
Cross-carotid bypass 1
Total debranching 0
Renal artery stenting 1
Distal bare stent 5
Visceral artery debranching 0
Conduit 1
Stroke 2
Paraplegia 0
Retrograde dissection 1
Intra-op bleeding, mL 195  192
Death 0
aCategoric data are shown as number (%); continuous data as mean  standlanding zone is often compromised because of its proximity so the arch vessels, and there is no healthy distal landing
one. The false lumen is not completely excluded, and
esidual fenestrations distal to the stent graft often perfuse
he false lumen in a retrograde fashion. Predicting the
type B aortic dissection (TBAD) and chronic dissection
en of all patients. B, Total thrombus volume in the false
ascular aneurysm repair for chronic type B aortic
Chronic dissection
with aneurysm
Total(n  15)
9 22 (69)
4 6 (19)
2 3 (9)
1 1 (3)
0 1 (3)
2 7 (22)
1 1 (3)
1 2 (6)
0 2 (6)
1 1 (3)
0 1 (3)
475  635 301  427
0 0
eviation.ronic
e lumndovtrength and behavior of the dissection flap is also difficult,
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achieved. The best indication of success would be a gradual
expansion of the true lumen, with a corresponding throm-
bosis and shrinkage of the false lumen and total aortic
volume. Theoretically, performing TEVAR early before
aneurysm formation, while the false lumen is small, may
improve the chance of complete remodeling and resolution
of the dissection.
In this study, we confirmed that a continuous and
dynamic remodeling process of the aortic lumens occurs in
the dissected thoracic aorta after TEVAR. Progressive gain
in true lumen volume, false lumen shrinkage, and throm-
bosis were evident, with corresponding enlargement in
stent graft inlet and outlet diameters. Sebastian et al11
found similar favorable volume changes in their study of 17
TEVAR-treated chronic type B aortic dissection patients.
When patients treated with TEVAR for uncomplicated
chronic type B aortic dissections were compared with those
with chronic dissections with aneurysms, we were unable to
demonstrate significant differences in all the morphologic
parameters between the two groups. There appears to be
no morphologic advantage to treating chronic type B dis-
sections before aneurysmal formation in view of potential
operative complications.
In addition, volumetric analysis detected increased aor-
tic volume during follow-up in eight patients (four in each
group), with no symptoms or endoleaks. Without volumet-
ric analysis, this might have been overlooked. In a study of
aortic volume in 20 patients with acute dissection treated
with TEVAR, Chemelli-Steingruber et al10 also observed
an initial favorable volume change after TEVAR for the first
2 years, but there was a return of aortic expansion after-
ward. No difference in volumetric parameters was evident
after 60 months compared with conservative treatment.10
It is very possible that TEVAR merely delayed the natural
course of the disease and aneurysm formation but could not
stop it completely. Our study does not support the hypoth-
esis that an early placement of an endograft will stop
aneurysmal progression in uncomplicated aortic dissec-
tions. A policy of regular imaging surveillance of uncom-
plicated type B dissections should be adopted, and TEVAR
should be reserved only for patients in whom aneurysm
formation has occurred.
A longer graft (162 mm) placed in the aorta resulted
in a significantly higher percentage of thrombosis in the
false lumen. A longer stent graft may possibly provide
stabilization of a longer-length of the dissection flap, reduc-
ing blood movements in the false lumen and resulting in a
higher thrombosis rate. However, this did not correlate
with a higher success rate in maintaining the aortic volume.
Longer grafts are often required in patients with more
extensive disease and may explain a higher chance of treat-
ment failure.
False lumen thrombosis is traditionally regarded as a
measure of success in TEVAR for treating type B aortic
dissection.12,13 However, residual distal fenestrations and
patent intercostal and lumbar arteries may still allow perfu-
sion and tension in the false lumen, leading to continuousxpansion. In addition, several previous studies revealed
hat mural thrombus is a proinflammatory factor and could
ctually increase the risk of rupture of aneurysms. Vorp et
l14 found that intraluminal thrombus could cause hypoxia
nd therefore lead to localized inflammation as well as
essel wall weakening. Kazi et al15 also argued that intralu-
inal thrombus “may perturb the structural integrity and
tability of the vessel wall and thereby increase the risk for
neurysm rupture.” Thrombus accumulated in the false
umen could, in similar mechanisms, potentially induce a
ocalized inflammatory response, smooth muscle cell apo-
tosis, mural neovascularization, and consequently,
eaken the aortic wall. Simple false lumen thrombosis may
ot be an entirely satisfactory end point when assessing
atients with TEVAR for dissections. Aortic volumemay be
better parameter in the long-term evaluation of patients
ith aortic dissections.
In this study, we found small and progressive migra-
ions of the stent graft within the true lumen, most obvious
uring the first 12 months after operation. The migrations
id not show any statistical significance between group A
nd B. A large dissecting aneurysm sac does not appear to
e detrimental to graft stability. Our previous investigation
f the hemodynamic drag forces acting on stent grafts in
ortic dissections found a 20% increase in drag forces over
2 months on the graft due to changes in stent graft
iameter after remodeling.16 Larger diameter grafts in-
urred a higher fluid displacement force, and the expansion
f the stent graft inlet diameter may contribute to these
light migrations. Longer stent grafts may bemore resistant
o migration due to their inherent higher contact surface of
he stents with the aortic wall and therefore a higher
xation force against the displacement drag forces.
ONCLUSIONS
Aortic remodeling after TEVAR in chronic dissection is
continuous process. There were no significant differences
etween chronic dissections and aneurysms in all volumet-
ic parameters. Treating chronic dissections early before
neurysm formation did not appear to have a morphologic
dvantage.
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Dr Vincent Rowe (Los Angeles, Calif). Thank you for allow-
ing me to review this interesting manuscript. Dr Cheng and his
team from Hong Kong did a magnificent job of detailing changes
seen in chronic uncomplicated type B aortic dissections with and
without aneurysmal degeneration. The authors utilized CT scans
and imaging software to provide volumetric data of the aorta over
a 36 month period poststenting. I believe this manuscript holds
significant merit because the radiologic findings found in this study
may help answer the question as to whether endografting should
become the primary treatment for type B aortic dissections. I do
have the following questions for the authors:
Question 1: In relation to the stent graft size, the authors
noted changes in the inlet and outlet area over the follow-up
period. Based on this, could the authors discuss how the stent
grafts were sized in their study at the time of implantation? Also,
based on their findings, could they provide any recommendations
as to the percent of oversizing required for the best outcome in
treating type B dissections?
Question 2: In the study, the authors had patients in both the
nonaneurysmal and aneurysmal group show an initial decrease in
aortic volume at 6 months and then an increase in total aortic
volume at 36months. In fact, 25% of patients ended the study with
an increase in their aortic volume and 37% showed no change in
aortic volume. This is compared to the results of the Investigation
of Stent Grafts in Aortic Dissection Trial, or INSTEAD trial, where
in the medical arm, 20% of patients progressed to require surgery
due to aneurysmal degeneration of 6 cm or greater. Based on these
findings, could the authors comment on the following:
A. Do you share the same conclusion of that trial in the belief that
in treating uncomplicated dissections with endografts, we are
merely delaying the inevitable progression of disease?
B. Did any of these patients go on to require a second interven-
tion?
C. Could endoleaks be the cause of increase of aortic volume?ould you please comment on the concept of only stenting across
he tear of the dissection and if they believe extension farther down
nto the descending thoracic aorta would be of benefit?
Thank you, Society, for allowing me to review this paper and I
ongratulate the authors on an insightful and well written manu-
cript.
Dr Stephen W. K. Cheng. Thank you, Dr Rowe, for your
omments and questions. We would like to answer your questions
s follows:
Answer 1: We generally oversize our stent grafts by 10-15%
hen treating type B aortic dissections. This is in keeping with the
eneral belief that aggressive oversizing may put the patient at a
igher risk of retrograde dissections and late distal landing zone
ears.
Answer 2A: One quarter of patients in this study showed an
ncrease in aortic volume on follow-up. There is some evidence
hat shows that TEVAR merely delays but is unable to stop the
isease progression in uncomplicated type B dissections, such as
hose published by Dr Chemelli-Steingruber in JVS in 2009. In his
resentation yesterday, Dr Melissano also showed similar trends
rom his series at 2 years. However, we believe a study with larger
umbers and longer follow-up is needed in order to draw any
onclusions. The significance of this study is that it answers the
uestion of timing to treat type B aortic dissections with TEVAR.
Answer 2B: Two patients in this study received secondary
eintervention. One of them was complicated with retrograde type
dissection and was treated successfully with proximal arch re-
lacement; the other patient developed progressive distal aneuris-
al enlargement of his thoracoabdominal aorta, and was also
uccessfully treated with a four-vessel fenestrated distal extension.
Answer 2C: Endoleaks in TEVAR-treated aortic dissections
re hard to define. The false lumens of type B aortic dissections
fter TEVAR are usually partially patent as there are always retro-
rade perfusions from the distal fenestrations or lumbar arteries.
herefore, we have reason to believe the endo-tension in the false
umen of TEVAR-treated type B aortic dissections is the cause of
he observed failure in those patients.
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May 20121276 Qing et alAnswer 3: In our study, longer stent grafts migrated less and
led tomore thrombosis in the false lumen, as the longer stent grafts
could stabilize the dissecting flaps better. We have moved toward
placing longer stent grafts for dissections for this reason. However,isk of failure. In our study, five patients out of eight with aortic
olume increase over 10%were treated with longer stent grafts, and
t seemed longer stent grafts had led to more failure in terms of
ortic volume change.longer stent grafts were also indicated when more complicated
anatomy was encountered, and these patients would be at a higher
Again, I thank the Society for granting us the opportunity to
present our study on this stage.
